Risk stratification for malignant upgrade in breast atypical hyperplasia: a Korean multi-institutional analysis from academic hospitals
Korean Journal of Clinical Oncology · 30.04.2026 · 22 (1) · 18-27
DOI: 10.14216/kjco.25363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Korean Journal of Clinical Oncology, online erschienen am 30.04.2026. Verfasst von Hyobin Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Korean Society of Surgical Oncology.
Abstract (Originalsprache)
Purpose
Atypical hyperplasia (AH) management remains controversial due to variable malignant disease progression rates. While Western studies report 10% to 25% upgrade rates, data from Asian populations, particularly from referral academic centers, are limited. We aimed to identify predictive factors for malignant upgrade in Korean women with AH at academic hospitals.
Methods
This retrospective multi-institutional study analyzed 340 patients diagnosed with AH on initial biopsy who underwent subsequent excision at five Korean academic hospitals from 2000 to 2022. Malignant upgrade was defined as ductal carcinoma in situ or invasive cancer on the final pathology. Multivariate logistic regression was used to identify independent predictors of upgrades.
Results
Among 340 patients (319 atypical ductal hyperplasia, 20 atypical lobular hyperplasia, and 1 mixed), 128 (37.6%) experienced a malignant upgrade, 98 (76.6%) to ductal carcinoma in situ, and 30 (23.4%) to invasive cancer. In multivariate analysis, multifocal atypia (odds ratio [OR], 25.61; 95% confidence interval [CI], 11.20–58.55; P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea.
- Division of Breast and Endocrine Surgery, Hallym University Sacred Heart Hospital, Anyang, Korea.
- Department of Surgery, Chung-Ang University College of Medicine, Seoul, Korea.
- Department of Surgery, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea.
- Department of AI Health Information Management, Yonsei University Mirae Campus, Wonju, Korea.
- Department of General Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Förderung
- Korean Society of Surgical Oncology
Zitieren
APA
Kim, H., Park, J. H., Kim, M. K., Cha, C., Lee, H., Oh, S. J., Choi, H., Yi, J. P., Lim, S. H., Kim, E. Y., & Kang, Y. J. (2026). Risk stratification for malignant upgrade in breast atypical hyperplasia: a Korean multi-institutional analysis from academic hospitals. Korean Journal of Clinical Oncology, 22(1), 18-27. https://doi.org/10.14216/kjco.25363
Vancouver
Kim H, Park JH, Kim MK, Cha C, Lee H, Oh SJ, et al. Risk stratification for malignant upgrade in breast atypical hyperplasia: a Korean multi-institutional analysis from academic hospitals. Korean Journal of Clinical Oncology. 2026;22(1):18-27. doi:10.14216/kjco.25363
BibTeX
@article{Kim2026,
author = {Kim, Hyobin and Park, Jung Ho and Kim, Min Kyoon and Cha, Chihwan and Lee, Hocheol and Oh, Se Jeong and Choi, Hoon and Yi, Jae Pak and Lim, Su Hyun and Kim, Eun Young and Kang, Young-Joon},
title = {Risk stratification for malignant upgrade in breast atypical hyperplasia: a Korean multi-institutional analysis from academic hospitals},
journal = {Korean Journal of Clinical Oncology},
year = {2026},
volume = {22},
number = {1},
pages = {18--27},
doi = {10.14216/kjco.25363}
}
EUVIMED